Authors


Steve H. Koh, MD, MPH

Latest:

What’s New in Depression?

The Chair of the Scientific Program Committee of APA 2016 offers an overview of the latest on depression.


Steve Koh, MD, MPH, MBA

Latest:

Introduction: The Scope of Psychiatry

Here's where psychiatry extends beyond a medical setting into collaborative, innovative, and integrated models of care..


Steve Schlozman, MD

Latest:

Child & Adolescent Psychiatry: An Overview of the Complex Challenges

We need to have a framework to make certain that our interventions are balanced, safe, and a function of the existing evidence.


Steven A. King, MD, MS

Latest:

Fibromyalgia: What It Is and How to Treat It

This CME covers the ins and outs of fibromyalgia, and everything a mental health professional needs to know when dealing with it.


Steven C. Dilsaver, MD

Latest:

Mixed States in Their Manifold Forms: Part 3

In Part 3 of this 3-part series, Dr Dilsaver discusses dichotomization versus a continuum model and concerns that bipolar disorders are over-diagnosed.


Steven D. Targum, MD

Latest:

Which Came First: Fatigue or Depression?

5 key questions to ask as part of a comprehensive differential assessment of fatigue and depression.


Steven Dilsaver, MD

Latest:

Recurrent Brief Mixed Depression

This case study of a 21-year-old woman-referred by a relative because of long-standing severe interpersonal, academic, and occupational impairment-illustrates the importance of screening patients with brief episodes of depression for mixed features.


Steven Dubovsky, MD

Latest:

Introduction: The Conventional Wisdom About Mood Disorders

What is the future of psychiatric assessment and treatment of mood disorders? The articles in this Special Report explore some important aspects and issues.


Steven H. Berger, MD

Latest:

Ethics and Dual Agency in Forensic Psychiatry

Dual agency often presents a confusing situation for the clinician who must simultaneously serve two separate roles in a legal case, such as a treatment role and a forensic role (Berger, 1997). The two roles have different purposes, procedures, relationships with the patient or evaluee, and different ethical principles.


Steven H. Hyler, MD

Latest:

Stigma Continues in Hollywood

Stereotypical portrayals of people with mental illness are as old as Hollywood itself. What are some of the clinical implications of the continued stigmatization of the mentally ill in television and film?


Steven J. Kingsbury, MD, PhD

Latest:

Psychiatric Polypharmacy: The Good, the Bad, and the Ugly

A great deal of data exists about the dangers of polypharmacy. Persons with psychiatric disorders experience increased risk for adverse drug interactions because of the great frequency with which multiple medications are used.


Steven J. Siegel, MD, PhD

Latest:

Predicting Outcome in Schizophrenia

Can sociodemographic and clinical variables predict outcome in cases of schizophrenia? Results from studies related to prognostic variables for schizophrenia have yielded interesting yet inconsistent results.


Steven L. Bernstein, MD

Latest:

Undertreatment of Tobacco Use Relative to Other Chronic Conditions

One might expect that treating nicotine use would be a leading priority for physicians. The reality is that this is not the case. More in this expert commentary, with practical tips for clinicians.


Steven P. Hamilton, MD, PhD

Latest:

The μ-Opioid System and Antidepressant Response

This article discusses the role of µ-opioid receptors (MORs) in antidepressant treatment and major depressive disorder (MDD). Specifically, it focuses on how the endogenous opioid system affects response to pharmaceuticals.


Steven P. Roose, MD

Latest:

Diagnosis and Treatment of Depressive and Memory Problems in Older Adults

What treatments are effective for mild chronic depression in older patients? Are there novel antidepressant medications with fewer adverse effects than current treatments? In this podcast, experts report on the latest updates in the evaluation and treatment of depression in older adults.


Steven Pflanz, MD

Latest:

The Art of the Unconscious

Theater, film, literature and poetry are forms of expression that allow artists and their audiences to explore the compelling issues of their lives. By understanding which pieces "speak" to patients and physicians, the dialogue and therapy may be enhanced.


Steven Phillips, MD

Latest:

Mini Quiz: Cognitive Enhancers

Which pharmacotherapeutic approach is most effective for cognitive enhancement? Test your knowledge with this quiz.


Steven R. Daviss, MD

Latest:

Update on Electronic Health Records and Health Care Technology

How to manage EHRs is at the top of the list of physician concerns, according to past AMA President Jeremy Lazarus, MD. The first psychiatrist to lead the AMA in over 70 years, Dr Lazarus addressed the Assembly at the American Psychiatric Association Annual Meeting in New York in May.


Steven S. Sharfstein, MD

Latest:

Psychiatrists Should Strongly Support Assisted Outpatient Treatment Programs

Assisted outpatient treatment is not intended to replace comprehensive, easy-to-access, voluntary treatment. Here's why we need it, according to one expert.


Steven Sugden, MD

Latest:

Drug Therapies for the Neurobehavioral Sequelae of Traumatic Brain Injury

Traumatic brain injury (TBI) is one of the most common causes of morbidity and mortality, especially in young adults. Recognition and early accurate diagnosis of neurobehavioral TBI sequelae are important in reducing the severity of postinjury symptoms. Sequelae of TBI include cognitive impairments, personality changes, aggression, impulsivity, apathy, anxiety, depression, mania, and psychosis.


Steven V. Faraone, PhD

Latest:

Diagnosing Adults With ADHD Based on Patient Presentation

Drs Stephen Faraone, Theresa Cerulli, Craig Chepke, and Andrew J. Cutler discuss how to diagnose adults with ADHD based on patient presentation.


Steven Zuckerman, MD

Latest:

Looming Technological Imperatives and the Physician-Patient Relationship

The past decade has seen an explosion of new drugs, procedures, and technology. This upward trajectory of health care breakthroughs shows no sign of slowing; such innovations as molecular imaging and pharmacogenetics are within years of going prime time.


Stuart C. Yudofsky, MD

Latest:

Neuropsychiatry: A Renaissance

The 5 papers in this Special Report on neuropsychiatry provide compelling evidence for the renaissance of neuropsychiatry as a clinical discipline. Wehave every reason to hope that this will lead to a better understanding of the complex interactions between brain and behavior and will reduce the artificial distinction between neurology and psychiatry.


Stuart Gitlow, MD, MPH, MBA

Latest:

Criteria for Social Security Psychiatric Disability

What is necessary in order to make a psychiatric disability determination? For one thing, treating clinicians should be aware of how the domains that are important for the consideration of impairment differ from the domains that are important to consider diagnostically.


Stuart L. Lustig, MD, MPH

Latest:

Telepsychiatry: Watching Your Back While Staying in the Black

Telehealth is at a tipping point and is gaining momentum. Although there are some technological and logistical hurdles, most clinicians would likely find these to be minor and outweighed by the benefits of expanding access to mental health care to those in need.


Stuart Lustig, MD, MPH

Latest:

Seeing the Forest Through the Fees: Earning Your Green Using the New, Confusing CPT Codes

E&M codes are more complicated to learn, but psychiatrists can now deservedly get paid more for treating their more complicated patients or for engaging in time-consuming activities. Here: a focus on codes 99212 to 99215.


Stuart N. Seidman, MD

Latest:

Testosterone Deficiency, Depression and Sexual Function in Aging Men

There is growing epidemiologic and clinical data that confirm progressive hypothalamic-pituitary-gonadal hypofunctioning in aging men. What role does the HPG axis play in the complex psychobiology of male sexual and affective disorders? The treatment rationale, clinical indications and risks in using exogenous testosterone for late-life depression are explored.


Stuart W. Twemlow, MD

Latest:

Preventing Violence in Schools

In the wake of the Columbine school shootings, it is of utmost importance for psychiatrists to be aware of the role they can play in preventing violence and bullying in our schools. What programs have been tried and how have they fared? What are the elements for a successful program?


Subani Maheshwari, MD

Latest:

Art Therapy in a Patient With Bipolar Disorder: Pictures Speak More Than a Thousand Words

Here: the case of a woman with bipolar disorder who was admitted for aggressive behavior and nonadherence to medications. Art therapy and pharmacotherapy played a pivotal role in her recovery.


Subramoniam Madhusoodanan, MD

Latest:

Managing Psychosis in Patients With Alzheimer Disease

Alzheimer disease psychosis appears to be a distinct clinical entity. This article focuses on management strategies.

© 2024 MJH Life Sciences

All rights reserved.